Cystospaz Oral Tablet 0.15Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Cystospaz: Oral tablet (0.15mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_1518.JPG
Cystospaz 0.15mg Tab
Amerifit Pharma, Inc.
Pill Identification: W 2225 
Drug Image file DrugItem_9290.JPG
Cystospaz 0.15mg Tab
Amerifit Pharma, Inc.
Pill Identification: W 2225 
Drug Image file DrugItem_6892.JPG
Hyoscyamine 0.15mg Tab
Prasco Laboratories
Pill Identification: 402  |  logo
Drug Image file DrugItem_4331.JPG
Hyoscyamine 0.15mg Tab
Breckenridge Inc
Pill Identification: H 111 

What is this Medicine?

HYOSCYAMINE (hye oh SYE a meen) is used to treat stomach and bladder problems. It is also used for rhinitis, to reduce some problems caused by Parkinson's disease, and for the treatment of poisoning with drugs that are usually used to treat myasthenia gravis.

In-Depth Information

Cystospaz 0.15mg Tablet

NDC: 614512225
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)




FDA approved for the following conditions:
Irritable Bowel Syndrome, Gastric Ulcer, Duodenal Ulcer

Cystospaz 0.15mg Tablet
Drug Image file DrugItem_1518.JPG
Amerifit Pharma, Inc.
Pill Identification: W 2225 
Shape: round
Color: blue
Drug Image file DrugItem_9290.JPG
Amerifit Pharma, Inc.
Pill Identification: W 2225 
Shape: round
Color: blue
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Cystospaz

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5